# OnCo record mablink-bioscience (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mablink-bioscience/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mablink-bioscience" ;
  schema:name "Mablink Bioscience"@en ;
  schema:description "Mablink Bioscience, from Lyon, invented PSARlink, a water-soluble polysarcosine linker that hides the greasy cell-killing payload so an antibody can carry a higher load of drug molecules and still stay stable in the blood. Eli Lilly bought the company in 2023, before any of its medicines had reached patients."@en ;
  schema:url <https://onco.cc/companies/mablink-bioscience/>, <https://www.lilly.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.lilly.com/>, <https://www.biospace.com/mablink-bioscience-enters-an-agreement-to-be-acquired-by-lilly> ;
  schema:addressCountry "FR" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> .